Anthony A Bavry

Summary

Affiliation: University of Florida
Country: USA

Publications

  1. pmc Nonsteroidal anti-inflammatory drugs and cardiovascular outcomes in women: results from the women's health initiative
    Anthony A Bavry
    From the North Florida South Georgia Veterans Health System, Gainesville, FL A A B Division of Cardiovascular Medicine, University of Florida, Gainesville A A B, M C L Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis F T, K C J Division of Preventive Medicine, University of California, San Diego, La Jolla M A MedStar Health Research Institute, Hyattsville, MD B V H Health Research and Policy Cardiovascular Medicine, Stanford University, CA M H and Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA J E M
    Circ Cardiovasc Qual Outcomes 7:603-10. 2014
  2. doi request reprint Harmful effects of NSAIDs among patients with hypertension and coronary artery disease
    Anthony A Bavry
    Department of Medicine, College of Medicine, University of Florida, Gainesville, 32610 0277, USA
    Am J Med 124:614-20. 2011
  3. pmc Outcomes Among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/Trandolapril STudy
    Anthony A Bavry
    Division of Cardiovascular Medicine, University of Florida, 1600 SW Archer Rd, PO Box 100277, Gainesville, FL 32610 0277, USA
    Hypertension 55:48-53. 2010
  4. doi request reprint Paving the coronaries with stents: okay in acute coronary syndromes?
    Anthony A Bavry
    Clin Cardiol 34:141-2. 2011
  5. pmc Simple integer risk score to determine prognosis of patients with hypertension and chronic stable coronary artery disease
    Anthony A Bavry
    College of Medicine, University of Florida, Gainesville, FL
    J Am Heart Assoc 2:e000205. 2013
  6. doi request reprint Efficacy and safety of unfractionated heparin plus glycoprotein IIb/IIIa inhibitors during revascularization for an acute coronary syndrome: a meta-analysis of randomized trials performed with stents and thienopyridines
    David E Winchester
    Department of Medicine, Division of Cardiovascular Medicine, University of Florida, Gainesville, Florida 32610, USA
    Clin Cardiol 35:93-100. 2012
  7. pmc Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy
    Scott J Denardo
    Division of Cardiovascular Medicine, College of Medicine, University of Florida, Gainesville, FL 32610, USA
    Am J Med 123:719-26. 2010
  8. pmc Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease
    Rhonda M Cooper-Dehoff
    Department of Pharmacotherapy and Translational Research and Division of Cardiovascular Medicine, College of Pharmacy, University of Florida, 1600 SW Archer Rd, PO Box 100486, Gainesville, FL 32610 0486, USA
    JAMA 304:61-8. 2010
  9. pmc Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertension
    Steven M Smith
    aDepartment of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, Colorado bDepartment of Pharmacotherapy and Translational Research, College of Pharmacy cDivision of Cardiovascular Medicine, Department of Medicine, College of Medicine, University of Florida, Gainesville, Florida dDivision of Cardiology, St Luke s Roosevelt Hospital, New York eDepartment of Preventive Medicine, Rush University, Chicago, Illinois fDepartments of Medicine and Epidemiology, Schools of Medicine and Public Health, University of Alabama Birmingham, Birmingham, Alabama, USA
    J Hypertens 32:635-43. 2014
  10. doi request reprint Impact of aspirin according to type of stable coronary artery disease: insights from a large international cohort
    Anthony A Bavry
    North Florida South Georgia Veterans Health System, Gainesville, Fla College of Medicine, University of Florida, Gainesville Electronic address
    Am J Med 128:137-43. 2015

Detail Information

Publications21

  1. pmc Nonsteroidal anti-inflammatory drugs and cardiovascular outcomes in women: results from the women's health initiative
    Anthony A Bavry
    From the North Florida South Georgia Veterans Health System, Gainesville, FL A A B Division of Cardiovascular Medicine, University of Florida, Gainesville A A B, M C L Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis F T, K C J Division of Preventive Medicine, University of California, San Diego, La Jolla M A MedStar Health Research Institute, Hyattsville, MD B V H Health Research and Policy Cardiovascular Medicine, Stanford University, CA M H and Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA J E M
    Circ Cardiovasc Qual Outcomes 7:603-10. 2014
    ..We hypothesized that regular NSAID use is associated with increased risk for cardiovascular events in postmenopausal women, and that this association is stronger with greater cyclooxygenase (cox)-2 when compared with cox-1 inhibition...
  2. doi request reprint Harmful effects of NSAIDs among patients with hypertension and coronary artery disease
    Anthony A Bavry
    Department of Medicine, College of Medicine, University of Florida, Gainesville, 32610 0277, USA
    Am J Med 124:614-20. 2011
    ..There is limited information about the safety of chronic nonsteroidal anti-inflammatory drugs (NSAIDs) in hypertensive patients with coronary artery disease...
  3. pmc Outcomes Among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/Trandolapril STudy
    Anthony A Bavry
    Division of Cardiovascular Medicine, University of Florida, 1600 SW Archer Rd, PO Box 100277, Gainesville, FL 32610 0277, USA
    Hypertension 55:48-53. 2010
    ..PAD patients displayed a J-shape relationship with systolic blood pressure and the primary outcome, although individuals without PAD did not. PAD patients may require a different target blood pressure than those without PAD...
  4. doi request reprint Paving the coronaries with stents: okay in acute coronary syndromes?
    Anthony A Bavry
    Clin Cardiol 34:141-2. 2011
  5. pmc Simple integer risk score to determine prognosis of patients with hypertension and chronic stable coronary artery disease
    Anthony A Bavry
    College of Medicine, University of Florida, Gainesville, FL
    J Am Heart Assoc 2:e000205. 2013
    ..It is difficult to accurately determine prognosis of patients with hypertension and chronic stable coronary artery disease (CAD). Our aim was to construct a risk score for predicting important adverse events in this population...
  6. doi request reprint Efficacy and safety of unfractionated heparin plus glycoprotein IIb/IIIa inhibitors during revascularization for an acute coronary syndrome: a meta-analysis of randomized trials performed with stents and thienopyridines
    David E Winchester
    Department of Medicine, Division of Cardiovascular Medicine, University of Florida, Gainesville, Florida 32610, USA
    Clin Cardiol 35:93-100. 2012
    ..Early studies of glycoprotein IIb/IIIa inhibitors (GPIs) demonstrated benefit during percutaneous coronary intervention for acute coronary syndromes (ACS). Since their introduction, the magnitude of benefit of GPIs has become unclear...
  7. pmc Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy
    Scott J Denardo
    Division of Cardiovascular Medicine, College of Medicine, University of Florida, Gainesville, FL 32610, USA
    Am J Med 123:719-26. 2010
    ..Our understanding of the growing population of very old patients (aged >or=80 years) with coronary artery disease and hypertension is limited, particularly the relationship between blood pressure and adverse outcomes...
  8. pmc Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease
    Rhonda M Cooper-Dehoff
    Department of Pharmacotherapy and Translational Research and Division of Cardiovascular Medicine, College of Pharmacy, University of Florida, 1600 SW Archer Rd, PO Box 100486, Gainesville, FL 32610 0486, USA
    JAMA 304:61-8. 2010
    ..Hypertension guidelines advocate treating systolic blood pressure (BP) to less than 130 mm Hg for patients with diabetes mellitus; however, data are lacking for the growing population who also have coronary artery disease (CAD)...
  9. pmc Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertension
    Steven M Smith
    aDepartment of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, Colorado bDepartment of Pharmacotherapy and Translational Research, College of Pharmacy cDivision of Cardiovascular Medicine, Department of Medicine, College of Medicine, University of Florida, Gainesville, Florida dDivision of Cardiology, St Luke s Roosevelt Hospital, New York eDepartment of Preventive Medicine, Rush University, Chicago, Illinois fDepartments of Medicine and Epidemiology, Schools of Medicine and Public Health, University of Alabama Birmingham, Birmingham, Alabama, USA
    J Hypertens 32:635-43. 2014
    ..In this post-hoc INternational VErapamil SR-Trandolapril STudy (INVEST) analysis, we assessed prevalence, predictors, and impact on outcomes of res-HTN in CAD patients with hypertension...
  10. doi request reprint Impact of aspirin according to type of stable coronary artery disease: insights from a large international cohort
    Anthony A Bavry
    North Florida South Georgia Veterans Health System, Gainesville, Fla College of Medicine, University of Florida, Gainesville Electronic address
    Am J Med 128:137-43. 2015
    ..We hypothesized that aspirin's benefit would be attenuated among individuals with stable coronary artery disease but no prior ischemic event...
  11. pmc Aldosterone inhibition and coronary endothelial function in women without obstructive coronary artery disease: an ancillary study of the national heart, lung, and blood institute-sponsored women's ischemia syndrome evaluation
    Anthony A Bavry
    North Florida South Georgia Veterans Health System, Gainesville, FL Division of Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, FL Electronic address
    Am Heart J 167:826-32. 2014
    ..Angiotensin II inhibition may improve endothelial function, but with continued treatment, "aldosterone escape" may occur. Thus, it is unknown if adding aldosterone blockade further improves endothelial function...
  12. doi request reprint Efficacy and safety of glycoprotein IIb/IIIa inhibitors during elective coronary revascularization: a meta-analysis of randomized trials performed in the era of stents and thienopyridines
    David E Winchester
    Department of Medicine, University of Florida, Gainesville, FL, USA
    J Am Coll Cardiol 57:1190-9. 2011
    ..The purpose of this study was to investigate the efficacy and safety of glycoprotein IIb/IIIa inhibitors (GPIs) during elective percutaneous coronary intervention (PCI)...
  13. pmc An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart, Lung and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE)
    Matheen A Khuddus
    Division of Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, Florida, USA
    J Interv Cardiol 23:511-9. 2010
    ..Information about the presence and characteristics of coronary atherosclerosis in these women could provide insight into the mechanisms related to increased risk, as well as improved diagnosis, prevention, and treatment...
  14. doi request reprint Efficacy and safety of Angiotensin receptor blockers in older patients: a meta-analysis of randomized trials
    Islam Y Elgendy
    Department of Medicine, University of Florida College of Medicine, Gainesville, Florida, USA
    Am J Hypertens 28:576-85. 2015
    ..The efficacy and safety of angiotensin receptor blockers (ARBs) in the older population is unclear...
  15. doi request reprint Aspirin: its risks, benefits, and optimal use in preventing cardiovascular events
    Ki Park
    Division of Cardiovascular Medicine, University of Florida, Gainesville, FL 32610, USA
    Cleve Clin J Med 80:318-26. 2013
    ..Recent studies have provided insight into the risks of aspirin use, particularly bleeding, compared with its benefits in these subgroups...
  16. doi request reprint Evidence of pre-procedural statin therapy a meta-analysis of randomized trials
    David E Winchester
    University of Florida, Gainesville, USA
    J Am Coll Cardiol 56:1099-109. 2010
    ..The purpose of this study was to summarize the evidence of pre-procedural statin therapy to reduce periprocedure cardiovascular events...
  17. doi request reprint Acute myocardial infarction during infusion of liposomal doxorubicin for recurrent breast cancer
    David E Winchester
    Division of Cardiovascular Medicine, University of Florida, Gainesville, Florida 32610 0277, USA
    Breast J 16:313-4. 2010
    ..To our knowledge, this is the first report of an angiographically proven infarction temporally related to exposure to this chemotherapeutic agent...
  18. pmc Risk of stroke associated with nonsteroidal anti-inflammatory drugs
    Ki Park
    Division of Cardiovascular Medicine, University of Florida, Gainesville, FL, USA
    Vasc Health Risk Manag 10:25-32. 2014
    ..In this review, we discuss the relevant literature assessing the possible association between NSAID use and stroke events, along with the potential mechanisms and the possible directions for future study. ..
  19. pmc The effect of hormone therapy on mean blood pressure and visit-to-visit blood pressure variability in postmenopausal women: results from the Women's Health Initiative randomized controlled trials
    Daichi Shimbo
    aDepartment of Medicine, Columbia University Medical Center, New York, New York bDivision of Preventive Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts cDepartment of Social and Preventive Medicine, School of Public Health and Health Professions, University at Buffalo SUNY, Buffalo, New York dDepartment of Family and Preventive Medicine, University of California San Diego, San Diego, California eDepartment of Epidemiology, Brown University, Providence, Rhode Island fDepartment of Medicine, North Florida South Georgia Veterans Health System, University of Florida, Gainesville, Florida gDivision of Cardiology, George Washington University, Washington, District of Columbia hFred Hutchinson Cancer Research Center, Seattle, Washington iCenter for Family and Community Medicine, Columbia University Medical Center, New York, New York jNational Heart, Lung, and Blood Institute, Bethesda, Maryland kDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York, USA
    J Hypertens 32:2071-81; discussion 2081. 2014
    ..We examined the effect of hormone therapy on mean and VVV of BP in postmenopausal women from the Women's Health Initiative (WHI) randomized controlled trials...
  20. doi request reprint Prevention of cardiovascular disease in women
    Anthony A Bavry
    Department of Medicine, University of Florida, Gainesville, Florida
    Semin Reprod Med 32:447-53. 2014
    ..Hormone therapy is no longer recommended due to an increase in adverse events (most consistently seen as increased ischemic stroke risk). Folic acid is also no longer recommended due to lack of benefit. ..
  21. doi request reprint Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials
    Anthony A Bavry
    Department of Cardiovascular Medicine, University of Florida, Gainesville, FL, USA
    Eur Heart J 29:2989-3001. 2008
    ..This study sought to determine whether the use of a thrombectomy or embolic protection device during revascularization for acute myocardial infarction reduces mortality compared with percutaneous coronary intervention (PCI) alone...